71 related articles for article (PubMed ID: 4010219)
1. [Philadelphia translocation and the human c-abl oncogene--relations in the light of molecular genetics].
Bartram CR; Grosveld G
Klin Padiatr; 1985; 197(3):196-202. PubMed ID: 4010219
[TBL] [Abstract][Full Text] [Related]
2. Expression of a translocated c-abl gene in hybrids of mouse fibroblasts and chronic myelogenous leukaemia cells.
Kozbor D; Giallongo A; Sierzega ME; Konopka JB; Witte ON; Showe LC; Croce CM
Nature; 1986 Jan 23-29; 319(6051):331-3. PubMed ID: 3455750
[TBL] [Abstract][Full Text] [Related]
3. [Molecular analysis of transformation into blast crisis in chronic myelogenous leukemia].
Okabe M
Hokkaido Igaku Zasshi; 1993 Mar; 68(2):237-50. PubMed ID: 8509066
[TBL] [Abstract][Full Text] [Related]
4. Fusion of the bcr and the c-abl genes in Ph'-positive acute lymphocytic leukemia with no rearrangement in the breakpoint cluster region.
ar-Rushdi A; Negrini M; Kurzrock R; Huebner K; Croce CM
Oncogene; 1988 Apr; 2(4):353-7. PubMed ID: 3283653
[TBL] [Abstract][Full Text] [Related]
5. Analysis of P210bcr-abl tyrosine protein kinase activity in various subtypes of Philadelphia chromosome-positive cells from chronic myelogenous leukemia patients.
Maxwell SA; Kurzrock R; Parsons SJ; Talpaz M; Gallick GE; Kloetzer WS; Arlinghaus RB; Kouttab NM; Keating MJ; Gutterman JU
Cancer Res; 1987 Mar; 47(6):1731-9. PubMed ID: 2434223
[TBL] [Abstract][Full Text] [Related]
6. The involvement of oncogenes and suppressor genes in human neoplasia.
Brodeur GM
Adv Pediatr; 1987; 34():1-44. PubMed ID: 3318293
[TBL] [Abstract][Full Text] [Related]
7. The bcr gene is joined to c-abl in Ph1 chromosome negative chronic myelogenous leukemia.
Dreazen O; Klisak I; Rassool F; Goldman JM; Sparkes RS; Gale RP
Oncogene Res; 1988; 2(2):167-75. PubMed ID: 3217110
[TBL] [Abstract][Full Text] [Related]
8. Transcriptional activation of human LIM-HOX gene, hLH-2, in chronic myelogenous leukemia is due to a cis-acting effect of Bcr-Abl.
Wu HK; Minden MD
Biochem Biophys Res Commun; 1997 Apr; 233(3):806-12. PubMed ID: 9168938
[TBL] [Abstract][Full Text] [Related]
9. Molecular insights into the Philadelphia translocation.
Heisterkamp N; Groffen J
Hematol Pathol; 1991; 5(1):1-10. PubMed ID: 2050600
[TBL] [Abstract][Full Text] [Related]
10. A cellular oncogene is translocated to the Philadelphia chromosome in chronic myelocytic leukaemia.
de Klein A; van Kessel AG; Grosveld G; Bartram CR; Hagemeijer A; Bootsma D; Spurr NK; Heisterkamp N; Groffen J; Stephenson JR
Nature; 1982 Dec; 300(5894):765-7. PubMed ID: 6960256
[TBL] [Abstract][Full Text] [Related]
11. The molecular biology of CML: a review.
Leibowitz D; Young KS
Cancer Invest; 1989; 7(2):195-203. PubMed ID: 2676087
[TBL] [Abstract][Full Text] [Related]
12. bcr rearrangement and translocation of the c-abl oncogene in Philadelphia positive acute lymphoblastic leukemia.
De Klein A; Hagemeijer A; Bartram CR; Houwen R; Hoefsloot L; Carbonell F; Chan L; Barnett M; Greaves M; Kleihauer E
Blood; 1986 Dec; 68(6):1369-75. PubMed ID: 3465378
[TBL] [Abstract][Full Text] [Related]
13. Rearrangement of the human ABL oncogene in a glioblastoma.
Heisterkamp N; Morris C; Sender L; Knoppel E; Uribe L; Cui MY; Groffen J
Cancer Res; 1990 Jun; 50(11):3429-34. PubMed ID: 2334939
[TBL] [Abstract][Full Text] [Related]
14. Complex chromosome rearrangements may locate the bcr/abl fusion gene sites other than 22q11.
Sessarego M; Fugazza G; Bruzzone R; Ballestrero A; Miglino M; Bacigalupo A
Haematologica; 2000 Jan; 85(1):35-9. PubMed ID: 10629589
[TBL] [Abstract][Full Text] [Related]
15. Characterization of the translocation breakpoint in a patient with Philadelphia positive, bcr negative acute lymphoblastic leukaemia.
van der Feltz MJ; Shivji MK; Grosveld G; Wiedemann LM
Oncogene; 1988 Aug; 3(2):215-9. PubMed ID: 3166123
[TBL] [Abstract][Full Text] [Related]
16. Localization of the human c-sis oncogene in Ph1-positive and Ph1-negative chronic myelocytic leukemia by in situ hybridization.
Bartram CR; de Klein A; Hagemeijer A; Grosveld G; Heisterkamp N; Groffen J
Blood; 1984 Jan; 63(1):223-5. PubMed ID: 6336312
[TBL] [Abstract][Full Text] [Related]
17. Genomic diversity correlates with clinical variation in Ph'-negative chronic myeloid leukaemia.
Morris CM; Reeve AE; Fitzgerald PH; Hollings PE; Beard ME; Heaton DC
Nature; 1986 Mar 20-26; 320(6059):281-3. PubMed ID: 3007992
[TBL] [Abstract][Full Text] [Related]
18. Structural organization of the bcr gene and its role in the Ph' translocation.
Heisterkamp N; Stam K; Groffen J; de Klein A; Grosveld G
Nature; 1985 Jun 27-Jul 3; 315(6022):758-61. PubMed ID: 2989703
[TBL] [Abstract][Full Text] [Related]
19. Molecular pathogenesis of chronic myelogenous leukaemia.
Ankathil R; Nair MK
Natl Med J India; 1992; 5(5):219-22. PubMed ID: 1302582
[TBL] [Abstract][Full Text] [Related]
20. C-abl and bcr are rearranged in a Ph1-negative CML patient.
Bartram CR; Kleihauer E; de Klein A; Grosveld G; Teyssier JR; Heisterkamp N; Groffen J
EMBO J; 1985 Mar; 4(3):683-6. PubMed ID: 3859408
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
